Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multibilayers (original) (raw)

Abstract

A membrane bilayer pathway model has been proposed for the interaction of dihydropyridine (DHP) calcium channel antagonists with receptors in cardiac sarcolemma (Rhodes, D.G., J.G. Sarmiento, and L.G. Herbette. 1985. Mol. Pharmacol. 27:612-623) involving drug partition into the bilayer with subsequent receptor binding mediated (though probably not rate-limited) by diffusion within the bilayer. Recently, we have characterized the partition step, demonstrating that DHPs reside, on a time-average basis, near the bilayer hydrocarbon core/water interface. Drug distribution about this interface may define a plane of local concentration for lateral diffusion within the membrane. The studies presented herein examine the diffusional dynamics of an active rhodamine-labeled DHP and a fluorescent phospholipid analogue (DiIC16) in pure cardiac sarcolemmal lipid multibilayer preparations as a function of bilayer hydration. At maximal bilayer hydration, the drug diffuses over macroscopic distances within the bilayer at a rate identical to that of DiI (D = 3.8 X 10(-8) cm2/s), demonstrating the overall feasibility of the membrane diffusion model. The diffusion coefficients for both drug and lipid decreased substantially as the bilayers were dehydrated. While identical at maximal hydration, drug diffusion was significantly slower than that of DiIC16 in partially dehydrated bilayers, probably reflecting differences in mass distribution of these probes in the bilayer.

1021

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Affolter H., Coronado R. Agonists Bay-K8644 and CGP-28392 open calcium channels reconstituted from skeletal muscle transverse tubules. Biophys J. 1985 Aug;48(2):341–347. doi: 10.1016/S0006-3495(85)83789-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bangham A. D., Standish M. M., Watkins J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965 Aug;13(1):238–252. doi: 10.1016/s0022-2836(65)80093-6. [DOI] [PubMed] [Google Scholar]
  3. Bean B. P. Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state. Proc Natl Acad Sci U S A. 1984 Oct;81(20):6388–6392. doi: 10.1073/pnas.81.20.6388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bellemann P., Schade A., Towart R. Dihydropyridine receptor in rat brain labeled with [3H]nimodipine. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2356–2360. doi: 10.1073/pnas.80.8.2356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bolger G. T., Gengo P., Klockowski R., Luchowski E., Siegel H., Janis R. A., Triggle A. M., Triggle D. J. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle. J Pharmacol Exp Ther. 1983 May;225(2):291–309. [PubMed] [Google Scholar]
  6. Clark N. A., Rothschild K. J., Luippold D. A., Simon B. A. Surface-induced lamellar orientation of multilayer membrane arrays. Theoretical analysis and a new method with application to purple membrane fragments. Biophys J. 1980 Jul;31(1):65–96. doi: 10.1016/S0006-3495(80)85041-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Colvin R. A., Ashavaid T. F., Herbette L. G. Structure-function studies of canine cardiac sarcolemmal membranes. I. Estimation of receptor site densities. Biochim Biophys Acta. 1985 Feb 14;812(3):601–608. doi: 10.1016/0005-2736(85)90253-6. [DOI] [PubMed] [Google Scholar]
  8. Eisinger J., Halperin B. I. Effects of spatial variation in membrane diffusibility and solubility on the lateral transport of membrane components. Biophys J. 1986 Sep;50(3):513–521. doi: 10.1016/S0006-3495(86)83489-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  10. Herbette L. G., Chester D. W., Rhodes D. G. Structural analysis of drug molecules in biological membranes. Biophys J. 1986 Jan;49(1):91–94. doi: 10.1016/S0006-3495(86)83605-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Herbette L., Marquardt J., Scarpa A., Blasie J. K. A direct analysis of lamellar x-ray diffraction from hydrated oriented multilayers of fully functional sarcoplasmic reticulum. Biophys J. 1977 Nov;20(2):245–272. doi: 10.1016/S0006-3495(77)85547-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hess P., Lansman J. B., Tsien R. W. Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature. 1984 Oct 11;311(5986):538–544. doi: 10.1038/311538a0. [DOI] [PubMed] [Google Scholar]
  13. Hof R. P., Rüegg U. T., Hof A., Vogel A. Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine. J Cardiovasc Pharmacol. 1985 Jul-Aug;7(4):689–693. doi: 10.1097/00005344-198507000-00012. [DOI] [PubMed] [Google Scholar]
  14. Janis R. A., Scriabine A. Sites of action of Ca2+ channel inhibitors. Biochem Pharmacol. 1983 Dec 1;32(23):3499–3507. doi: 10.1016/0006-2952(83)90295-2. [DOI] [PubMed] [Google Scholar]
  15. Jones L. R., Maddock S. W., Besch H. R., Jr Unmasking effect of alamethicin on the (Na+,K+)-ATPase, beta-adrenergic receptor-coupled adenylate cyclase, and cAMP-dependent protein kinase activities of cardiac sarcolemmal vesicles. J Biol Chem. 1980 Oct 25;255(20):9971–9980. [PubMed] [Google Scholar]
  16. Kongsamut S., Kamp T. J., Miller R. J., Sanguinetti M. C. Calcium channel agonist and antagonist effects of the stereoisomers of the dihydropyridine 202-791. Biochem Biophys Res Commun. 1985 Jul 16;130(1):141–148. doi: 10.1016/0006-291x(85)90393-6. [DOI] [PubMed] [Google Scholar]
  17. Koppel D. E. Fluorescence redistribution after photobleaching. A new multipoint analysis of membrane translational dynamics. Biophys J. 1979 Nov;28(2):281–291. doi: 10.1016/S0006-3495(79)85176-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Koppel D. E., Sheetz M. P. A localized pattern photobleaching method for the concurrent analysis of rapid and slow diffusion processes. Biophys J. 1983 Aug;43(2):175–181. doi: 10.1016/S0006-3495(83)84338-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Langs D. A., Triggle D. J. Conformational features of calcium channel agonist and antagonist analogs of nifedipine. Mol Pharmacol. 1985 May;27(5):544–548. [PubMed] [Google Scholar]
  20. Lee K. S., Tsien R. W. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature. 1983 Apr 28;302(5911):790–794. doi: 10.1038/302790a0. [DOI] [PubMed] [Google Scholar]
  21. McCloskey M. A., Poo M. M. Rates of membrane-associated reactions: reduction of dimensionality revisited. J Cell Biol. 1986 Jan;102(1):88–96. doi: 10.1083/jcb.102.1.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. McCown J. T., Evans E., Diehl S., Wiles H. C. Degree of hydration and lateral diffusion in phospholipid multibilayers. Biochemistry. 1981 May 26;20(11):3134–3138. doi: 10.1021/bi00514a023. [DOI] [PubMed] [Google Scholar]
  23. Rhodes D. G., Sarmiento J. G., Herbette L. G. Kinetics of binding of membrane-active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site. Mol Pharmacol. 1985 Jun;27(6):612–623. [PubMed] [Google Scholar]
  24. Sarmiento J. G., Janis R. A., Katz A. M., Triggle D. J. Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranes. Biochem Pharmacol. 1984 Oct 15;33(20):3119–3123. doi: 10.1016/0006-2952(84)90066-2. [DOI] [PubMed] [Google Scholar]
  25. Vaz W. L., Clegg R. M., Hallmann D. Translational diffusion of lipids in liquid crystalline phase phosphatidylcholine multibilayers. A comparison of experiment with theory. Biochemistry. 1985 Jan 29;24(3):781–786. doi: 10.1021/bi00324a037. [DOI] [PubMed] [Google Scholar]